APPLICATION
ANDA205379
TYPE
ANDA
ORIGINAL APPROVAL
2015-09-25
LATEST ACTION
2025-04-17
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
ESOMEPRAZOLE SODIUMDiscontinued
ESOMEPRAZOLE SODIUM EQ 40MG BASE/VIAL · INJECTABLE · INTRAVENOUS
Approval history
2025-04-17Labeling · Supplement 10 · standardAP
2020-04-17Labeling · Supplement 6 · standardAP
2020-04-17Labeling · Supplement 4 · standardAP
2020-04-17Labeling · Supplement 2 · standardAP
2020-04-17Labeling · Supplement 7 · standardAP
2020-04-17Labeling · Supplement 3 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.